190 related articles for article (PubMed ID: 18558355)
21. Testing on formalin-fixed neutrophils is less sensitive and specific for small vessel vasculitis, and less sensitive for MPO-ANCA, than most ELISAs.
Pollock W; Trevisin M; Savige J;
J Immunol Methods; 2008 Dec; 339(2):141-5. PubMed ID: 18823991
[TBL] [Abstract][Full Text] [Related]
22. Determination of anti-neutrophil cytoplasmic antibodies in small vessel vasculitis: Comparative analysis of different strategies.
Vermeersch P; Vervaeke S; Blockmans D; van Hoovels L; Mariën G; Vanmaele H; Bossuyt X
Clin Chim Acta; 2008 Nov; 397(1-2):77-81. PubMed ID: 18708041
[TBL] [Abstract][Full Text] [Related]
23. Anti-myeloperoxidase and anti-cathepsin G antibodies in sulphonamide hypersensitivity.
Lavergne SN; Drescher NJ; Trepanier LA
Clin Exp Allergy; 2008 Jan; 38(1):199-207. PubMed ID: 17976219
[TBL] [Abstract][Full Text] [Related]
24. IgG subclass distribution and relative functional affinity of anti-myeloperoxidase antibodies in systemic vasculitis at presentation and during follow-up.
Esnault VL; Jayne DR; Weetman AP; Lockwood CM
Immunology; 1991 Dec; 74(4):714-8. PubMed ID: 1664417
[TBL] [Abstract][Full Text] [Related]
25. Myeloperoxidase and its contributory role in inflammatory vascular disease.
Lau D; Baldus S
Pharmacol Ther; 2006 Jul; 111(1):16-26. PubMed ID: 16476484
[TBL] [Abstract][Full Text] [Related]
26. Retardation of early-onset PMA-induced apoptosis in mouse neutrophils deficient in myeloperoxidase.
Tsurubuchi T; Aratani Y; Maeda N; Koyama H
J Leukoc Biol; 2001 Jul; 70(1):52-8. PubMed ID: 11435485
[TBL] [Abstract][Full Text] [Related]
27. Successful pregnancy and delivery of a healthy newborn despite transplacental transfer of antimyeloperoxidase antibodies from a mother with microscopic polyangiitis.
Silva F; Specks U; Sethi S; Irazabal MV; Fervenza FC
Am J Kidney Dis; 2009 Sep; 54(3):542-5. PubMed ID: 19395136
[TBL] [Abstract][Full Text] [Related]
28. Circulating myeloperoxidase may cause false negative findings in the analysis of myeloperoxidase antibodies in systemic vasculitis.
Haapala AM; Soppi E; Hyöty H
Scand J Immunol; 1994 Sep; 40(3):317-22. PubMed ID: 8091131
[TBL] [Abstract][Full Text] [Related]
29. Development and validation of a screening procedure for the assessment of inhibition using a recombinant enzyme.
Van Antwerpen P; Moreau P; Zouaoui Boudjeltia K; Babar S; Dufrasne F; Moguilevsky N; Vanhaeverbeek M; Ducobu J; Nève J
Talanta; 2008 Apr; 75(2):503-10. PubMed ID: 18371913
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of the myeloperoxidase chlorinating activity by non-steroidal anti-inflammatory drugs: flufenamic acid and its 5-chloro-derivative directly interact with a recombinant human myeloperoxidase to inhibit the synthesis of hypochlorous acid.
Van Antwerpen P; Dufrasne F; Lequeux M; Boudjeltia KZ; Lessgyer I; Babar S; Moreau P; Moguilevsky N; Vanhaeverbeek M; Ducobu J; Nève J
Eur J Pharmacol; 2007 Sep; 570(1-3):235-43. PubMed ID: 17610876
[TBL] [Abstract][Full Text] [Related]
31. The inhibition of myeloperoxidase by ceruloplasmin can be reversed by anti-myeloperoxidase antibodies.
Griffin SV; Chapman PT; Lianos EA; Lockwood CM
Kidney Int; 1999 Mar; 55(3):917-25. PubMed ID: 10027928
[TBL] [Abstract][Full Text] [Related]
32. Oxygen radical-induced natural killer cell dysfunction: role of myeloperoxidase and regulation by serotonin.
Betten A; Dahlgren C; Mellqvist UH; Hermodsson S; Hellstrand K
J Leukoc Biol; 2004 Jun; 75(6):1111-5. PubMed ID: 15039463
[TBL] [Abstract][Full Text] [Related]
33. Serum concentration of interleukin-18 is up-regulated in patients with ANCA-associated vasculitis.
Hultgren O; Andersson B; Hahn-Zoric M; Almroth G
Autoimmunity; 2007 Nov; 40(7):529-31. PubMed ID: 17966043
[TBL] [Abstract][Full Text] [Related]
34. MCLA-dependent chemiluminescence suggests that singlet oxygen plays a pivotal role in myeloperoxidase-catalysed bactericidal action in neutrophil phagosomes.
Arisawa F; Tatsuzawa H; Kambayashi Y; Kuwano H; Fujimori K; Nakano M
Luminescence; 2003; 18(4):229-38. PubMed ID: 12950060
[TBL] [Abstract][Full Text] [Related]
35. Cutaneous manifestations in patients with microscopic polyangiitis: two case reports and a minireview.
Kawakami T; Soma Y; Saito C; Ogawa H; Nagahuchi Y; Okazaki T; Ozaki S; Mizoguchi M
Acta Derm Venereol; 2006; 86(2):144-7. PubMed ID: 16648918
[TBL] [Abstract][Full Text] [Related]
36. In vivo role of myeloperoxidase for the host defense.
Aratani Y; Kura F; Watanabe H; Akagawa H; Takano Y; Suzuki K; Dinauer MC; Maeda N; Koyama H
Jpn J Infect Dis; 2004 Oct; 57(5):S15. PubMed ID: 15507755
[TBL] [Abstract][Full Text] [Related]
37. Reactions of superoxide with myeloperoxidase and its products.
Winterbourn CC; Kettle AJ
Jpn J Infect Dis; 2004 Oct; 57(5):S31-3. PubMed ID: 15507767
[TBL] [Abstract][Full Text] [Related]
38. PF-1355, a mechanism-based myeloperoxidase inhibitor, prevents immune complex vasculitis and anti-glomerular basement membrane glomerulonephritis.
Zheng W; Warner R; Ruggeri R; Su C; Cortes C; Skoura A; Ward J; Ahn K; Kalgutkar A; Sun D; Maurer TS; Bonin PD; Okerberg C; Bobrowski W; Kawabe T; Zhang Y; Coskran T; Bell S; Kapoor B; Johnson K; Buckbinder L
J Pharmacol Exp Ther; 2015 May; 353(2):288-98. PubMed ID: 25698787
[TBL] [Abstract][Full Text] [Related]
39. Activation of equine neutrophils by phorbol myristate acetate or N-formyl-methionyl-leucyl-phenylalanine induces a different response in reactive oxygen species production and release of active myeloperoxidase.
Franck T; Kohnen S; de la Rebière G; Deby-Dupont G; Deby C; Niesten A; Serteyn D
Vet Immunol Immunopathol; 2009 Aug; 130(3-4):243-50. PubMed ID: 19328559
[TBL] [Abstract][Full Text] [Related]
40. ANCA-small vessel vasculitides: what have we (not yet) learned from animal models?
van der Veen BS; Heeringa P
APMIS Suppl; 2009 Jun; (127):21-6. PubMed ID: 19515135
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
